FY24 sbir phase i topic no. 459 project title: an automated screening platform for early identification of malnutrition in cancer patients
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91024C00094
- Awardee
-
Biosensics LLC UEI C9MRZK4B7K39
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $400,000
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20241 · Posted Jul 7, 2023
- Contract value 100% obligated
- $400,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 17 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Newtonville, MA 02458, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Original award | $400,000 |
About this award
This is a $400,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Biosensics LLC, a small business located in Newtonville, Massachusetts. The contract is for the development of an automated screening platform to enable early identification of malnutrition in cancer patients. This contract award is part of the FY24 SBIR solicitation, which covers a variety of research topics across multiple NIH and Centers for Disease Control and Prevention (CDC) institutes and centers. The purpose of the SBIR program is to stimulate technological innovation and strengthen the role of small businesses in meeting federal research and development needs.
Quick answers
Who was awarded contract 75N91024C00094?
75N91024C00094 was awarded to Biosensics LLC by National Cancer Institute (National Institutes of Health) on September 11, 2024.
How much is contract 75N91024C00094 worth?
The government has obligated $400,000 on 75N91024C00094.
Was contract 75N91024C00094 competed?
The extent of competition for 75N91024C00094 was full and open competition after exclusion of sources. The government received 17 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award